Previous close | 22.70 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 725 |
Market cap | 20.886B |
Beta (5Y monthly) | 0.80 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.25 |
Earnings date | 29 July 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 12 May 2022 |
1y target est | N/A |
Philips MR 5300 BlueSeal installation at Vida Imaging & Breast Center, Bayamon, Puerto Rico Exterior picture of Vida Imaging & Breast Center, Bayamon, Puerto Rico A clinician using a Philips MR 5300 May 30, 2024 First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto Rico Amsterdam, the Netherlands and Bayamón, Puerto Rico – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and world leader in proven helium-free [1] MRI ope
Philips (PHG) expands its international footprint with the wide availability of VeriSight Pro 3D to several Hong Kong hospitals, strengthening its Diagnosis & Treatment segment.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.